Data Safety Monitoring Committee has approved continuation of Radiopharm's Phase 1 trial for 177Lu-RAD204, allowing progression to a higher dose cohort without protocol modifications.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.